Patents-Review.com
ClassID:

21040 ⎘

A61K38/4873 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Enzymes; Proenzymes; Derivatives thereof; Hydrolases (3) acting on peptide bonds (3.4) Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H

Recent Application in this class:
#1
20260137743
2026-05-21

METHODS OF RELIEVING PAIN

 #2
20260130990
2026-05-14

METHODS FOR IMPROVED THERAPEUTIC USE OF RECOMBINANT AAV

 #3
20260115147
2026-04-30

DISSOLVABLE GEL-FORMING FILM FOR DELIVERY OF ACTIVE AGENTS

 #4
20260102475
2026-04-16

REGIMEN FOR ENZYMATIC DESENSITISATION

 #5
20260053870
2026-02-26

METHANOLYTIC AGENTS AND METHODS OF USING THE SAME

 #6
20260021168
2026-01-22

CONDITIONING REGIMEN FOR CELL TRANSPLANT

 #7
20260016491
2026-01-15

METHODS FOR THE TREATMENT OF SYMPTOMS OF NEUROLOGICAL AND MENTAL HEALTH DISORDERS

 #8
20260007711
2026-01-08

NUTRACEUTICAL FORMULATIONS TO PREVENT, TREAT, AND INHIBIT EXCESS CYTOKINES, SARS-CoV-2 SPIKE PROTEINS, AND mRNA VACCINE SPIKE PROTEIN

 #9
20260002175
2026-01-01

METHODS OF TREATING MUSCULAR DYSTROPHY

 #10
20260000739
2026-01-01

METHOD FOR IMPROVING THE BENEFIT TO A SUBJECT OF A THERAPY OR THERAPEUTIC AGENT

 #11
20250352503
2025-11-20

BIO-OPTIMIZED NUTRACEUTICAL DIETARY SUPPLEMENT

 #12
20250325640
2025-10-23

METHODS FOR ENHANCING ADOPTIVE CELL TRANSFER IMMUNOTHERAPIES

 #13
20250277048
2025-09-04

THE USE OF CD40 INHIBITORS FOR INHIBITING AN IMMUNE RESPONSE AND ENABLING IMMUNOGEN ADMINISTRATION AND RE-ADMINISTRATION

 #14
20250268995
2025-08-28

COMPOSITIONS FOR BREAKDOWN OF GLUTEN PROTEINS

 #15
20250262285
2025-08-21

Topical Formulations for Reducing Bruising and/or Pain

 #16
20250249083
2025-08-07

PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF THE SYMPTOMS OF ADDICTION AND METHOD OF DIAGNOSING SAME

 #17
20250134819
2025-05-01

ORAL DOSAGE FORM WITH A GASTRO RESISTANT CAPSULE SHELL

 #18
20250034228
2025-01-30

IMMUNE CELL COMPOSITIONS AND METHODS OF USE

 #19
20250009857
2025-01-09

NUTRACEUTICAL COMPOSITION BASED ON PINEAPPLE AND PLANT EXTRACTS FOR THE TREATMENT OF IRRITABLE BOWEL SYNDROME

 #20
20250009856
2025-01-09

METHODS FOR TREATING RESPIRATORY DISEASES

 #21
20240425839
2024-12-26

MODIFIED CASPASE-9 POLYPEPTIDES AND METHODS OF USE THEREOF

 #22
20240409911
2024-12-12

FC FUSION MOLECULES AND USES THEREOF

 #23
20240382433
2024-11-21

DISSOLVABLE GEL-FORMING FILM FOR DELIVERY OF ACTIVE AGENTS

 #24
20240335520
2024-10-10

A VACCINE FOR PROTECTION AGAINST STREPTOCOCCUS SUIS OF VARIOUS SEROTYPES

 #25
20240307513
2024-09-19

METHOD FOR TREATING AND/OR IMPROVING INFLAMMATORY INTESTINAL DISEASE

 #26
20240285735
2024-08-29

METHODS OF DEBRIDEMENT OF CHRONIC WOUNDS

 #27
20240271115
2024-08-15

METHODS AND COMPOSITIONS FOR DEPLETING ANTIBODIES

 #28
20240245615
2024-07-25

Implantable Device for Sustained Release of a Macromolecular Drug Compound

 #29
20240226250
2024-07-11

MODIFIED NEUROTOXIN SINGLE-CHAIN POLYPEPTIDE AND USE THEREOF

 #30
20240226153
2024-07-11

COMPOSITIONS AND METHODS FOR SELECTIVE ELIMINATION AND REPLACEMENT OF HEMATOPOIETIC STEM CELLS

 #31
20240216484
2024-07-04

BROMELAIN PROTEASE, BROMELAIN, JACALIN-LIKE LECTIN, EXTRACT FROM THE STEM AND/OR THE FRUIT OF A PINEAPPLE PLANT, COMBINATION PREPARATION, BROMELAIN PROTEASE INHIBITOR, PROTEIN/PROTEASE MIX, AND GLYCATED BROMELAIN PROTEIN FORMED BY EXOGENOUS NON-ENZYMATIC GLYCATION, FOR USE IN THE TREATMENT OR PROPHYLAXIS OF VIRUS INFECTIONS CAUSED BY CORONAVIRUSES IN A HUMAN OR ANIMAL

 #32
20240167011
2024-05-23

Fc fusion molecules and uses thereof

 #33
20240150494
2024-05-09

GLYCOFORM SPECIFIC NANOBODIES AND METHODS OF USE

 #34
20240148842
2024-05-09

PROTEOLYTIC ENZYME MIXTURE FOR TREATING PSORIASIS

 #35
20240131127
2024-04-25

MODIFIED NEUROTOXIN SINGLE-CHAIN POLYPEPTIDE AND USE THEREOF

 #36
20240131067
2024-04-25

COMPOSITIONS AND METHODS FOR SELECTIVE ELIMINATION AND REPLACEMENT OF HEMATOPOIETIC STEM CELLS

 #37
20240124913
2024-04-18

Protein-Based Signal Amplification

 #38
20240115671
2024-04-11

INTRACELLULAR DELIVERY OF THERAPEUTIC PROTEINS DESIGNED TO INVADE AND AUTONOMOUSLY LYSE AND METHODS OF USE THEREOF

 #39
20240091324
2024-03-21

GASTROINTESTINAL HEALTH COMPOSITION

 #40
20240075112
2024-03-07

SCAR TREATMENT COMPOSITION

 #41
20230414728
2023-12-28

METHODS OF TREATING SKIN CANCERS

 #42
20230364207
2023-11-16

MUTANT OF IMMUNOGLOBULIN DEGRADING ENZYME IDEE

 #43
20230364054
2023-11-16

METHODS FOR TREATING COVID-19

 #44
20230355726
2023-11-09

FIBRINOLYTIC ENZYME COMPOSITION FOR FIBROSIS TREATMENT

 #45
20230346866
2023-11-02

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING NON-MALIGNANT RESPIRATORY DISEASE

 #46
20230295241
2023-09-21

ARTIFICIAL ALPHAVIRUS-DERIVED RNA REPLICON EXPRESSION SYSTEMS

 #47
20230285520
2023-09-14

DEVELOPMENT OF A NEW ENGINEERED TOBACCO ETCH VIRUS (TEV) PROTEASE ACTIVABLE IN THE CYTOSOL OR SECRETORY PATHWAY

 #48
20230277633
2023-09-07

PHARMACEUTICAL COMPOSITION OF ENZYMES AND VIRUSES AND APPLICATION THEREOF

 #49
20230277470
2023-09-07

Implantable device for sustained release of a macromolecular drug compound

 #50
20230270831
2023-08-31

METHODS FOR INDUCING SELECTIVE APOPTOSIS

 #51
20230263867
2023-08-24

PROTEASE COMPOSITION

 #52
20230241188
2023-08-03

PREVENTING AND TREATING VIRAL INFECTIONS

 #53
20230226160
2023-07-20

COMPOSITIONS AND METHODS FOR TREATING BACTERIAL INFECTIONS

 #54
20230210962
2023-07-06

CONDITIONING REGIMEN FOR TRANSPLANT

 #55
20230181701
2023-06-15

METHODS FOR ENHANCING ADOPTIVE CELL TRANSFER IMMUNOTHERAPIES

 #56
20230173040
2023-06-08

METHODS AND COMPOSITIONS FOR ATI DIGESTION

 #57
20230142731
2023-05-11

COMPOSITIONS AND METHODS FOR INCREASING OR ENHANCING TRANSDUCTION OF GENE THERAPY VECTORS AND FOR REMOVING OR REDUCING IMMUNOGLOBULINS

 #58
20230142078
2023-05-11

ENHANCEMENT AND STABILISATION OF PROTEOLYTIC ACTIVITY OF PROTEASES

 #59
20230134432
2023-05-04

COMPOSITIONS AND METHODS FOR TREATING SOLID AND SOFT TUMORS AND PROLIFERATIVE DISEASES

 #60
20230127775
2023-04-27

METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOIDOSIS

 #61
20230110085
2023-04-13

IMMUNOGLOBULIN DETECTION AND ASSOCIATED THERAPIES

 #62
20230055292
2023-02-23

Dissolvable gel-forming film for delivery of active agents

 #63
20230038577
2023-02-09

NUTRACEUTICAL FORMULATIONS TO PREVENT, TREAT, AND INHIBIT EXCESS CYTOKINES, SARS-CoV-2 SPIKE PROTEINS, AND mRNA VACCINE SPIKE PROTEINS

 #64
20230037325
2023-02-09

COMPOSITIONS AND METHODS FOR TREATING WOUNDS IN LIVESTOCK

 #65
20230000958
2023-01-05

Immune Booster Food Supplement

 #66
20220401529
2022-12-22

TREATMENT OF DISEASES INVOLVING MUCIN

 #67
20220395488
2022-12-15

Methods for treating COVID-19

 #68
20220370555
2022-11-24

Selective cell death-inducing enzyme system

 #69
20220347298
2022-11-03

METHODS FOR IMPROVED THERAPEUTIC USE OF RECOMBINANT AAV

 #70
20220323535
2022-10-13

HEALTH SUPPLEMENT

 #71
20220323390
2022-10-13

DIETARY SUPPLEMENT TO PROMOTE GUT HEALTH

 #72
20220298210
2022-09-22

Artificial alphavirus-derived RNA replicon expression systems

 #73
20220296526
2022-09-22

CANNABINOID COMPOSITIONS, METHODS OF MAKING SAME AND USES THEREOF

 #74
20220235346
2022-07-28

Modified caspase-9 polypeptides and methods of use thereof

 #75
20220202902
2022-06-30

COMPOSITIONS COMPRISING A TWEAK LIGAND AND METHODS OF USING SAME

 #76
20220125837
2022-04-28

METHODS FOR CONTROLLED ELIMINATION OF THERAPEUTIC CELLS

 #77
20220118064
2022-04-21

MULTI-SUPPLEMENT COMPOSITIONS

 #78
20220112263
2022-04-14

Immune cell compositions and methods of use

 #79
20220106608
2022-04-07

FUSOGENIC LIPID NANOPARTICLES FOR THE TARGET CELL-SPECIFIC PRODUCTION OF RAPAMYCIN INDUCIBLE THERAPEUTIC PROTEINS

 #80
20220105161
2022-04-07

PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF THE SYMPTOMS OF ADDICTION AND METHOD OF DIAGNOSING SAME

 #81
20220062360
2022-03-03

CANNABINOID COMPOSITION AND METHOD OF SUBLINGUAL, BUCCAL AND ORAL MUCOSA DELIVERY

 #82
20220054427
2022-02-24

TRANSDERMAL COMPOSITION

 #83
20210379137
2021-12-09

Pharmaceutical composition for use in the treatment of prostate pathologies

 #84
20210322500
2021-10-21

Method for producing stable powder with high level bioactive actinidin enzyme

 #85
20210270846
2021-09-02

METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF NEUROLOGICAL AND MENTAL HEALTH DISORDERS

 #86
20210260173
2021-08-26

METHOD

 #87
20210246469
2021-08-12

COMPOSITIONS AND METHODS FOR INCREASING OR ENHANCING TRANSDUCTION OF GENE THERAPY VECTORS AND FOR REMOVING OR REDUCING IMMUNOGLOBULINS

 #88
20210244924
2021-08-12

Mask assembly for face

 #89
20210244805
2021-08-12

PHARMACEUTICAL FOR PREVENTION OF BLEOMYCIN-INDUCED PULMONARY FIBROSIS

 #90
20210228694
2021-07-29

METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOIDOSIS

 #91
20210219589
2021-07-22

CANNABINOID EMULSION PRODUCT AND PROCESS FOR MAKING THE SAME

 #92
20210145945
2021-05-20

Radioprotection, Radiomitigation and Radiorecovery

 #93
20210106037
2021-04-15

FOOD SUPPLEMENT FOR USE IN A PROCESS OF METABOLIC REBALANCING

 #94
20210046166
2021-02-18

Systems for treating dermal inflammatory conditions

 #95
20210032333
2021-02-04

Methods and Compositions for Reducing Immunogenicity By Non-Depletional B Cell Inhibitors

 #96
20210023023
2021-01-28

LIPOSOMAL NUTRACEUTICAL COMPOSITIONS AND METHODS OF MAKING THE SAME

 #97
20210008180
2021-01-14

FORMULATIONS CONTAINING MUCIN-AFFECTING PROTEASES

 #98
20200376057
2020-12-03

Cannabinoid composition and method of sublingual, buccal and oral mucosa delivery

 #99
20200370029
2020-11-26

COMPOSITION COMPRISING A GENE VECTOR THAT SELECTIVELY DEPLETES P16 POSITIVE SENESCENT CELLS

 #100
20200345653
2020-11-05

Transdermal Composition

 #101
20200323929
2020-10-15

COMPOSITION OF PROBIOTICS AND DIGESTIVE ENZYMES AND METHOD OF PREPARING AND USING THE SAME

 #102
20200282030
2020-09-10

Methods and Compositions for the Prevention and Treatment of Influenza

 #103
20200230216
2020-07-23

Methods for inducing partial apoptosis using caspase polypeptides

 #104
20200164026
2020-05-28

Intranasal Delivery of Cell Permeant Therapeutics

 #105
20200129656
2020-04-30

ENZYMATIC WOUND DEBRIDING COMPOSITIONS WITH ENHANCED ENZYMATIC ACTIVITY

 #106
20200113982
2020-04-16

Composition and Uses Thereof

 #107
20200078402
2020-03-12

Compositions and methods for selective elimination and replacement of hematopoietic stem cells

 #108
20200046007
2020-02-13

Cannabinoid emulsion product and process for making the same

 #109
20200030421
2020-01-30

METHODS FOR INDUCING SELECTIVE APOPTOSIS

 #110
20190374574
2019-12-12

Composition for the treatment of gastrointestinal disorders

 #111
20190358167
2019-11-28

Implantable device for sustained release of a macromolecular drug compound

 #112
20190316109
2019-10-17

Composition comprising a gene vector that selectively depletes P16 positive senescent cells

 #113
20190307860
2019-10-10

LATIGLUTENASE (ALV003) FOR USE IN THE TREATMENT OF SYMPTOMATIC CELIAC DISEASE, GLUTEN INTOLERANCE OR GLUTEN SENSITIVITY

 #114
20190256562
2019-08-22

Group A streptococcus vaccine

 #115
20190209667
2019-07-11

METHOD FOR DIAGNOSING AND TREATING DYSAUTONOMIA AND OTHER DYSAUTONOMIC CONDITIONS

 #116
20190201507
2019-07-04

METHODS AND COMPOSITIONS FOR THE TREATMENT OF SYMPTOMS OF COMPLEX REGIONAL PAIN SYNDROME

 #117
20190183985
2019-06-20

METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOIDOSIS

 #118
20190183977
2019-06-20

Compositions and methods for reducing tumor cell growth at a site of solid tumor excision

 #119
20190175704
2019-06-13

Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same

 #120
20190142911
2019-05-16

NOVEL COMPOSITIONS FOR THE TREATMENT OF CANCER

 #121
20190142910
2019-05-16

METHODS OF DEBRIDEMENT OF CHRONIC WOUNDS

 #122
20190136215
2019-05-09

Replication conditional virus that specifically kills senescent cells

 #123
20190127721
2019-05-02

Modified caspase-9 polypeptides and methods of use thereof

 #124
20190105378
2019-04-11

SELECTIVE CELL-DEATH-INDUCING BINARY ENZYME SYSTEM

 #125
20190105377
2019-04-11

METHODS AND MATERIALS FOR MODULATING DEUBIQUITINASES AND UBIQUITINATED POLYPEPTIDES

 #126
20190105338
2019-04-11

Gut health compositions

 #127
20190070314
2019-03-07

Nano/micromotors for active and dynamic intracellular payload delivery

 #128
20190060509
2019-02-28

Enzymatic wound debriding compositions with enhanced enzymatic activity

 #129
20190060361
2019-02-28

METHODS AND COMPOSITIONS RELATING TO REGULATORY T CELLS

 #130
20190054157
2019-02-21

COMPOSITION AND METHOD OF PREPARATION OF PROTEASE MICROPARTICULATE SLOW RELEASE PREPARATION

 #131
20190030140
2019-01-31

Debriding composition for treating wounds

 #132
20190030139
2019-01-31

USP10 MODULATION OF AMPK AND MTOR

 #133
20190010477
2019-01-10

Compositions for the treatment of gluten intolerance and uses thereof

 #134
20190008927
2019-01-10

Composition For Enzymatic Debridement

 #135
20190000931
2019-01-03

DIETARY SUPPLEMENTS AND FORMULATIONS

 #136
20190000930
2019-01-03

DIETARY SUPPLEMENTS AND FORMULATIONS

 #137
20180318402
2018-11-08

COMPOSITIONS AND METHODS COMPRISING SERRATIA PEPTIDASE FOR INHIBITION AND TREATMENT OF BIOFILMS RELATED TO CERTAIN CONDITIONS

 #138
20180303916
2018-10-25

Compositions and methods for the treatment of diseases involving mucin

 #139
20180273601
2018-09-27

Immune cell compositions and methods of use

 #140
20180271961
2018-09-27

METHODS FOR INDUCING SELECTIVE APOPTOSIS

 #141
20180264091
2018-09-20

ENZYMATIC FRACTIONS WITH ANTI-INFLAMMATORY ACTIVITY

 #142
20180256752
2018-09-13

Selective gene therapy expression system

 #143
20180251746
2018-09-06

MODIFIED CASPASE POLYPEPTIDES AND USES THEREOF

 #144
20180243385
2018-08-30

Methods for inducing selective apoptosis

 #145
20180243384
2018-08-30

Methods for inducing partial apoptosis using caspase polypeptides

 #146
20180161409
2018-06-14

Method of diagnosing preeclampsia or pregnancy-induced hypertension

 #147
20180153970
2018-06-07

COMPOSITION AND USES THEREOF

 #148
20180139997
2018-05-24

FOOD SUPPLEMENT FOR USE IN A PROCESS OF METABOLIC REBALANCING

 #149
20180116986
2018-05-03

COMPOSITION OF NOVEL POWDER FORMULATIONS OF TRANEXAMIC ACID

 #150
20180085489
2018-03-29

Amine-functionalized polymeric compositions for medical devices

 #151
20180078623
2018-03-22

Methods and compositions for the treatment of symptoms of prion diseases

 #152
20180071375
2018-03-15

Methods and Compositions for the Treatment of Symptoms of Complex Regional Pain Syndrome

 #153
20180071374
2018-03-15

Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same

 #154
20180036392
2018-02-08

TREATMENT OF ECZMA WITH COMPOSITIONS CONTAINING BROMELAIN

 #155
20180036391
2018-02-08

TREATMENT OF DERMAL ITCH WITH COMPOSITIONS CONTAINING BROMELAIN

 #156
20180036390
2018-02-08

Treatment of rosacea with compositions containing bromelain

 #157
20170369546
2017-12-28

BMP peptides and methods of use

 #158
20170360986
2017-12-21

Collagenous tissue repair device

 #159
20170360903
2017-12-21

Systems for treating dermal inflammatory conditions

 #160
20170354594
2017-12-14

PROTEASE COMPOSITIONS FOR USE IN MODIFYING SEMEN

 #161
20170348390
2017-12-07

Compositions and methods for treating mesothelioma post-surgery

 #162
20170333536
2017-11-23

Composition and method of preparation of protease microparticulate slow release preparation

 #163
20170304411
2017-10-26

TOPICAL FORMULATION FOR TREATING SKIN OR MUCOSAL INFECTIONS, PREPARATION METHOD AND USES THEREOF

 #164
20170290894
2017-10-12

Compositions and methods for treating thyroid disease

 #165
20170266127
2017-09-21

Cannabinoid emulsion product and process for making the same

 #166
20170247674
2017-08-31

CONJUGATES FOR DELIVERY TO MITOCHONDRIA

 #167
20170239334
2017-08-24

ANTI-DIARRHEA FORMULATION WHICH AVOIDS ANTIMICROBIAL RESISTANCE

 #168
20170209550
2017-07-27

Method for improving the benefit of organ transplant

 #169
20170209463
2017-07-27

Dietary supplement compositions for cardiovascular health

 #170
20170202934
2017-07-20

Methods and compositions for the prevention and treatment of influenza

 #171
20170151314
2017-06-01

Compositions and kits for enzymatic debridement and methods of using the same

 #172
20170119861
2017-05-04

METHODS AND COMPOSITIONS FOR THE TREATMENT OF AMYLOIDOSIS

 #173
20170100464
2017-04-13

Dental gel composition of papain for the atraumatic treatment of caries and method of preparing same

 #174
20170095541
2017-04-06

NOVEL COMPOSITIONS FOR THE TREATMENT OF CANCER

 #175
20170072029
2017-03-16

Enzymatic wound debriding compositions with enhanced enzymatic activity

 #176
20170049865
2017-02-23

Proteolytic extract from bromelain for the treatment of connective tissue disorders

 #177
20170037087
2017-02-09

Group A vaccine

 #178
20170028037
2017-02-02

Reduced-pressure treatment systems and methods employing debridement mechanisms

 #179
20170020996
2017-01-26

ENZYMATIC DEBRIDEMENT THERAPY FOR ABNORMAL CELL PROLIFERATION

 #180
20170015987
2017-01-19

Modified Caspase polypeptides and uses thereof

 #181
20170000856
2017-01-05

Dietary supplements and formulations

 #182
20170000830
2017-01-05

Compositions for Relieving the Symptoms of Gluten Sensitivity and Methods of Use Thereof

 #183
20160361393
2016-12-15

TOPICAL STING/BITE FORMULATION AND METHOD OF USE

 #184
20160312293
2016-10-27

Method of predicting a response to an anti-tumor treatment

 #185
20160287683
2016-10-06

Method of treating proteinuria in pregnancy

 #186
20160279257
2016-09-29

Compositions and methods relating to nucleic acid-protein complexes

 #187
20160250292
2016-09-01

In vivo individualized systemic immunotherapeutic method and device

 #188
20160235825
2016-08-18

Formulation for oral administration of proteins

 #189
20160228519
2016-08-11

Therapeutic vegetable substances

 #190
20160206708
2016-07-21

Methods and compositions for the treatment of symptoms of Williams Syndrome

 #191
20160199461
2016-07-14

Treatment of synucleinopathies

 #192
20160193306
2016-07-07

Multi-supplement compositions

 #193
20160166613
2016-06-16

METHODS FOR CONTROLLED ELIMINATION OF THERAPEUTIC CELLS

 #194
20160151465
2016-06-02

Methods for inducing partial apoptosis using caspase polypeptides

 #195
20160136249
2016-05-19

Compositions for the treatment of cancer

 #196
20160136248
2016-05-19

Methods and materials for treating cancers that express reduced levels of wild-type p53 polypeptides

 #197
20160114012
2016-04-28

Enzyme formulation for use as food supplement

 #198
20160095320
2016-04-07

Mixture to increase the effectiveness of antiseptics and/or disinfectants, an agent containing the mixture, and the use of this mixture

 #199
20160058890
2016-03-03

Selective gene therapy expression system

 #200
20160058849
2016-03-03

Treatment of synucleinopathies

 #201
20160038573
2016-02-11

SELECTIVE CELL-DEATH-INDUCING BINARY ENZYME SYSTEM

 #202
20160008293
2016-01-14

Dissolvable gel-forming film for delivery of active agents

 #203
20150366954
2015-12-24

Methods for inducing selective apoptosis

 #204
20150359860
2015-12-17

Method of treating fibrosis in skeletal muscle tissue

 #205
20150352195
2015-12-10

Methods and pharmaceutical compositions for treating celiac disease and gluten intolerance

 #206
20150343035
2015-12-03

Treatment of diseases involving mucin

 #207
20150328292
2015-11-19

CASPASE POLYPEPTIDES HAVING MODIFIED ACTIVITY AND USES THEREOF

 #208
20150297687
2015-10-22

PROTEASE COMPOSITIONS FOR THE TREATMENT OF DAMAGED TISSUE

 #209
20150297685
2015-10-22

FIBRINOLYTIC COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF PHLEBOTHROMBOTIC STATES

 #210
20150273030
2015-10-01

Methods and compositions for the treatment of symptoms of prion diseases

 #211
20150246995
2015-09-03

Amine-functionalized polymeric compositions for medical devices

 #212
20150238576
2015-08-27

Topical therapeutic compositions containing bromelain

 #213
20150223747
2015-08-13

PATIENT REPORTED OUTCOME INSTRUMENT

 #214
20150197738
2015-07-16

Acid Stable Prolyl Endopeptidases for Degrading Gluten

 #215
20150184146
2015-07-02

Formulation for Oral Administration of Proteins

 #216
20150182607
2015-07-02

Use of proteases for gluten intolerance

 #217
20150174220
2015-06-25

Method of treating pregnancy-induced hypertension

 #218
20150174219
2015-06-25

Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same

 #219
20150132273
2015-05-14

Nutritional Compositions and Methods for Treating Cognitive Impairment

 #220
20150071993
2015-03-12

Compositions and methods for improving sleep using a nutraceutical formulation

 #221
20150064163
2015-03-05

BMP Peptides & Methods of Use

 #222
20150064137
2015-03-05

USE OF ENGINEERED VIRUSES TO SPECIFICALLY KILL SENESCENT CELLS

 #223
20150037315
2015-02-05

Dietary supplement for managing gut health

 #224
20150023944
2015-01-22

Method of treating and diagnosing Parkinson's disease and related dysautonomic disorders

 #225
20140370570
2014-12-18

Use of a cysteine protease of plasmodium vivax

 #226
20140363420
2014-12-11

Method and composition for topical pain relief

 #227
20140328818
2014-11-06

Proteases for degrading gluten

 #228
20140286929
2014-09-25

Proteomic IPF markers

 #229
20140271609
2014-09-18

Methods of treatment of cellulite

 #230
20140271608
2014-09-18

Resorption enhancers as additives to improve the oral formulation of low molecular weight heparins

 #231
20140248258
2014-09-04

METHODS FOR IMPROVING GUT HEALTH

 #232
20140205587
2014-07-24

Proteases for Degrading Gluten

 #233
20140170115
2014-06-19

Enzyme and prebiotic combinations for enhancing probiotic growth and efficacy

 #234
20140161789
2014-06-12

Therapeutic vegetable substances

 #235
20140161787
2014-06-12

Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same

 #236
20140161784
2014-06-12

Compositions and methods for enhancing recovery after surgery or an athletic performance

 #237
20140154229
2014-06-05

Proteolytic extract from bromelain for the treatment of connective tissue disorders

 #238
20140147433
2014-05-29

Methods and devices suitable for improved reattachment of detached cartilage to subchondral bone

 #239
20140142026
2014-05-22

Anti-Pathogen Treatments

 #240
20140134112
2014-05-15

Topical pharmaceutical foam composition

 #241
20140037748
2014-02-06

REDOX RESPONSIVE POLYMERIC NANOCAPSULES FOR PROTEIN DELIVERY

 #242
20140030333
2014-01-30

Method of treating toxemia

 #243
20140010788
2014-01-09

Administration of enzyme and prebiotic combinations that enhance probiotic growth and efficacy

 #244
20130344051
2013-12-26

Compostion of matter for treating or preventing various types of cancer and neoplastic diseases in a mammal

 #245
20130287757
2013-10-31

COMPOSITION FOR THE REGENERATION OF ATROPHIC TISSUES

 #246
20130236445
2013-09-12

Bromelain proteinases (Bromelainases) as chemotherapeutic agents in treating and/or preventing various types of cancer in a mammal

 #247
20130224169
2013-08-29

Composition and method for recovery from mild traumatic brain injury

 #248
20130195833
2013-08-01

Methods and compositions for the treatment of symptoms of prion diseases

 #249
20130177549
2013-07-11

Treatment of synucleinopathies

 #250
20130156745
2013-06-20

Composition for enzymatic debridement

 #251
20130108613
2013-05-02

Amyloid-beta clearance

 #252
20130059001
2013-03-07

Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same

 #253
20130045196
2013-02-21

Enzymatic wound debriding compositions with enhanced enzymatic activity

 #254
20130034531
2013-02-07

Use of proteases for gluten intolerance

 #255
20130028884
2013-01-31

COMPOSITION AND METHOD FOR TREATMENT OF BRUISING

 #256
20130004565
2013-01-03

Proteolytic enzyme formulations

 #257
20120308553
2012-12-06

ORAL MEDICATION FOR THE TREATMENT OF HEMORRHOIDS AND METHOD OF USE

 #258
20120258149
2012-10-11

Methods and compositions for the treatment of influenza

 #259
20120225050
2012-09-06

Methods for improving gut health

 #260
20120219542
2012-08-30

Podocyte pH modulation and uses thereof

 #261
20120213764
2012-08-23

NOVEL METHOD FOR THE PRODUCTION OF A ANTIMICROBIAL PEPTIDE

 #262
20120197003
2012-08-02

Modified oligopeptides for the treatment of pancreatitis, stomach ulcers, and other hyperenzymemias based on enzyme peptide inhibitors and methods for obtaining them

 #263
20120171192
2012-07-05

Methods and materials for modulating deubiquitinases and ubiquitinated polypeptides

 #264
20120171187
2012-07-05

Debriding composition from bromelain and methods of production thereof

 #265
20120156188
2012-06-21

CHEMICAL METHOD FOR SEXUAL STERILIZATION AND LIBIDO ELIMINATION IN MALE MAMMALS

 #266
20120144504
2012-06-07

CASPASE-8 AND SKIN DISEASE

 #267
20120128598
2012-05-24

Topical Pharmaceutical Foam Composition

 #268
20120104047
2012-05-03

Composition for Relief of Insect Bites and Stings and Apparatus and Method for Its Delivery

 #269
20120076769
2012-03-29

HERBAL COMPOSITION FOR CANCER TREATMENT

 #270
20120076768
2012-03-29

Digestive/laxative compositions

 #271
20120070504
2012-03-22

Pharmaceutical preparation for the treatment of the symptoms of addiction and method of diagnosing same

 #272
20120070423
2012-03-22

ORAL COMPOSITION AND METHOD OF FORMING AND USING SAME

 #273
20120034299
2012-02-09

Compositions for the treatment of gluten intolerance and uses thereof

 #274
20120034200
2012-02-09

Formulations including digestive enzymes, polysorbate-based surfactants and probiotics

 #275
20120020947
2012-01-26

COMPOSITIONS AND METHODS FOR INCREASING LEAN MUSCLE MASS AFTER EXERCISE

 #276
20120010499
2012-01-12

USE OF NANOPARTICLES FOR THE TREATMENT OF CANCER

 #277
20110311509
2011-12-22

Treatment of ocular diseases

 #278
20110300124
2011-12-08

SOAKING AGENT FOR THE TREATMENT OF HEMORRHOIDS AND METHOD OF USE

 #279
20110293639
2011-12-01

System for selective cell treatment using ideotypically modulated pharmacoeffectors

 #280
20110286980
2011-11-24

Methods for inducing selective apoptosis

 #281
20110280855
2011-11-17

VITAMIN C COMPOSITIONS

 #282
20110243918
2011-10-06

TOPICAL MEDICATION FOR THE TREATMENT OF HEMORRHOIDS AND METHOD OF USE

 #283
20110236397
2011-09-29

LIMITED PROTEOLYSIS OF CD2AP AND PROGRESSION OF RENAL DISEASE

 #284
20110236369
2011-09-29

Dosage forms that facilitate rapid activation of barley protease zymogen

 #285
20110236368
2011-09-29

ORAL MEDICATION FOR THE TREATMENT OF HEMORRHOIDS AND METHOD OF USE

 #286
20110200574
2011-08-18

USE OF PROTEASES FOR GLUTEN INTOLERANCE

 #287
20110182874
2011-07-28

Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions

 #288
20110182873
2011-07-28

Methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions

 #289
20110182818
2011-07-28

Methods and compositions for the treatment of symptoms of neurological and mental health disorders

 #290
20110177052
2011-07-21

Stabilized proteases that have been immobilized and further crosslinked for use in skin care

 #291
20110177050
2011-07-21

Methods comprising serratia peptidase for inhibition of osteomyelitis

 #292
20110177049
2011-07-21

Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions

 #293
20110177048
2011-07-21

Compositions and methods comprising serratia peptidase for inhibition of bacterial vaginosis, bacterial vaginitis or fungal vaginitis

 #294
20110171201
2011-07-14

Formulation for oral administration of proteins

 #295
20110171189
2011-07-14

COMPOSITIONS AND METHODS COMPRISING SERRATIA PEPTIDASE FOR INHIBITION AND TREATMENT OF BIOFILMS RELATED TO CERTAIN CONDITIONS

 #296
20110135627
2011-06-09

PAIN RELIEF COMPOSITION, SYSTEM AND METHOD

 #297
20110129454
2011-06-02

Methods of comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions

 #298
20110104283
2011-05-05

Compositions and methods of natural products in nanoformulations for the prevention and treatment of osteoporosis

 #299
20110097383
2011-04-28

APPARATUS AND METHODS FOR ENZYMATIC ESCHAROTOMY IN BURN INDUCED COMPARTMENT SYNDROME

 #300
20110097316
2011-04-28

COMPOSITION TO BE ABSORBED THROUGH MUCOUS TISSUE